Reducing the minimum detectable change in vastus lateralis fat fraction using MRI in clinical trials for Duchenne muscular dystrophy (DMD) therapy

被引：0
|
作者：
Hammond, M. [1 ]
Roche, F. [2 ]
Harris, J. [1 ]
Luna, B. [1 ]
Mary, J. [2 ]
Berger, M. [1 ]
Vincent, F. [2 ]
Zabbatino, S. [1 ]
Heinichen, L. [3 ]
Scheyer, R. [3 ]
Holland, S. [1 ]
机构：
[1] Medpace Core Labs, Cincinnati, OH USA
[2] Medpace Core Labs, Lyon, France
[3] Medpace, Cincinnati, OH USA
来源：
NEUROMUSCULAR DISORDERS | 2021年 / 31卷
关键词：
D O I：
10.1016/j.nmd.2021.07.360
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP.335
引用
收藏
页码：S152 / S152
页数：1
相关论文
共 49 条
  • [21] Association of Elbow Flexor MRI Fat Fraction With Loss of Hand-to-Mouth Movement in Patients With Duchenne Muscular Dystrophy
    Naarding, Karin J.
    van der Holst, Menno
    van Zwet, Erik W.
    van de Velde, Nienke M.
    de Groot, Imelda J. M.
    Verschuuren, Jan J. G. M.
    Kan, Hermien E.
    Niks, Erik H.
    NEUROLOGY, 2021, 97 (17) : E1737 - E1742
  • [22] Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments
    Gaeta, Michele
    Messina, Sonia
    Mileto, Achille
    Vita, Gian Luca
    Ascenti, Giorgio
    Vinci, Sergio
    Bottari, Antonio
    Vita, Giuseppe
    Settineri, Nicola
    Bruschetta, Daniele
    Racchiusa, Sergio
    Minutoli, Fabio
    SKELETAL RADIOLOGY, 2012, 41 (08) : 955 - 961
  • [23] Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials
    Ricotti, Valeria
    Evans, Matthew R. B.
    Sinclair, Christopher D. J.
    Butler, Jordan W.
    Ridout, Deborah A.
    Hogrel, Jean-Yves
    Emira, Ahmed
    Morrow, Jasper M.
    Reilly, Mary M.
    Hanna, Michael G.
    Janiczek, Robert L.
    Matthews, Paul M.
    Yousry, Tarek A.
    Muntoni, Francesco
    Thornton, John S.
    PLOS ONE, 2016, 11 (09):
  • [24] Corticosteroids in Duchenne muscular dystrophy: impact on the motor function measure sensitivity to change and implications for clinical trials
    Schreiber, Audrey
    Brochard, Sylvain
    Rippert, Pascal
    Fontaine-Carbonnel, Stephanie
    Payan, Christine
    Poirot, Isabelle
    Hamroun, Dalil
    Vuillerot, Carole
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2018, 60 (02): : 185 - 191
  • [25] Steroids in Duchenne muscular dystrophy (DMD): Natural history and clinical evaluation using the North Star Ambulatory Assessment (NSAA)
    Eagle, M.
    Scott, E.
    Main, M.
    Sheehan, J.
    Michelle, M.
    Guglieri, M.
    Straub, V.
    Bushby, K.
    NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 774 - 774
  • [26] Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessmentsPreliminary experience
    Michele Gaeta
    Sonia Messina
    Achille Mileto
    Gian Luca Vita
    Giorgio Ascenti
    Sergio Vinci
    Antonio Bottari
    Giuseppe Vita
    Nicola Settineri
    Daniele Bruschetta
    Sergio Racchiusa
    Fabio Minutoli
    Skeletal Radiology, 2012, 41 : 955 - 961
  • [27] Best-worst scaling analysis of priorities for participation in gene therapy clinical trials for Duchenne muscular dystrophy
    McNiff, M.
    Heslop, E.
    Denger, B.
    Hill, C.
    Cope, H.
    Camino, E.
    Johnson, A.
    Fischer, R.
    Peay, H.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S173 - S173
  • [28] Using Actigraphy for Understanding Activity and Sleep Patterns in Young Boys With Duchenne Muscular Dystrophy (DMD) During a Clinical Drug Trial
    Silverman, Natalie
    Beck, Michelle
    Hall, Danielle
    Hartman, Amy
    Bendixen, Roxanna
    AMERICAN JOURNAL OF OCCUPATIONAL THERAPY, 2020, 74 (04):
  • [29] Comparative economic impact of therapeutic innovation on health care burden of Duchenne Muscular Dystrophy (DMD) using Becker Muscular Dystrophy (BMD) as a comparator for potential clinical outcome corridor
    Schreiber, O.
    Klug, C.
    Thiele, S.
    Schorling, E.
    Zowe, J.
    Reilich, P.
    Nagels, K.
    Walter, M. C.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 855 - 855
  • [30] MRI in Duchenne muscular dystrophy: Quantification of fat infiltration and gadolinium uptake using whole-muscle regions of interest
    Garrood, P.
    Hollingsworth, K.
    Thelwall, P.
    Birchall, D.
    Eagle, M.
    Bushby, K.
    Straub, V.
    NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 816 - 817
12345